Compare · RPID vs WAT
RPID vs WAT
Side-by-side comparison of Rapid Micro Biosystems Inc. (RPID) and Waters Corporation (WAT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RPID and WAT operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- WAT is the larger of the two at $43.64B, about 1029.4x RPID ($42.4M).
- WAT has been more active in the news (4 items in the past 4 weeks vs 1 for RPID).
- WAT has more recent analyst coverage (25 ratings vs 11 for RPID).
- Company
- Rapid Micro Biosystems Inc.
- Waters Corporation
- Price
- -
- -
- Market cap
- $42.4M
- $43.64B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 1995
- News (4w)
- 1
- 4
- Recent ratings
- 11
- 25
Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Latest RPID
- Roth Capital initiated coverage on Rapid Micro Biosystems with a new price target
- Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by Rapid Micro Biosystems Inc.
- Rapid Micro Biosystems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
- Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Director Kollender Richard S exercised 3,508 shares at a strike of $0.75, increasing direct ownership by 3% to 133,826 units (SEC Form 4)
- PRESIDENT AND CEO Spignesi Robert G. Jr. exercised 1,402 shares at a strike of $0.75, increasing direct ownership by 0.12% to 1,191,973 units (SEC Form 4)
- Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
- Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Latest WAT
- Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
- Director Knight Heather was granted 57 shares, increasing direct ownership by 4% to 1,338 units (SEC Form 4)
- Director Jiang Wei was granted 57 shares, increasing direct ownership by 2% to 3,630 units (SEC Form 4)
- Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
- Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
- Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
- UBS resumed coverage on Waters with a new price target
- SEC Form 3 filed by new insider Wu Tong (Nmn)
- Waters upgraded by Piper Sandler with a new price target
- Waters Corporation to Present at the Wells Fargo Healthcare Conference